Results 11 to 20 of about 208,827 (271)

Genomic-Based Epidemiological Analysis of the Post-Pandemic <i>Mycoplasma pneumoniae</i> Resurgence. [PDF]

MedComm (2020)
Phylogenetic analysis of a global collection of 562 M. pneumoniae genomes revealed six distinct lineages, including three newly emerged main Chinese clades (MCCs) that co‐circulated in various regions of China. The recent emergence of these distinct clades and their differing geographical distributions may suggest ongoing divergent evolution within the
Liu H, Zheng X, Du X, Wang Y, Xiang Y, Wang Q, Tian S, Xian Y, Chen W, Liu H, Wang H, Wang C, Yang M, Jia H, Li X, Dan Y, Tong L, Deng G, Li H, Wang F, Song H, Qiu S.   +21 more
europepmc   +2 more sources

Respiratory microbiota imbalance in children with Mycoplasma pneumoniae pneumonia

Emerging Microbes and Infections, 2023
Although previous studies have reported the dysregulation of respiratory tract microbiota in infectious diseases, insufficient data exist regarding respiratory microbiota imbalances in the lower respiratory tracts (LRTs) of children with Mycoplasma ...
Ya-cui Wang, Xiaoran Yu, Fang Liu, Xue Tian, Shuting Quan, A. Jiao, Xuemei Yang, Xianfen Zeng, W. Jiao, Hui Qi, Fang Xu, Qin-jing Li, Shuping Liu, Bao-Ping Xu, Lin Sun, A. Shen   +15 more
semanticscholar   +1 more source

Thromboembolic complications of Mycoplasma pneumoniae pneumonia in children

Clinical Respiratory Journal, 2023
Thromboembolism is less common in children than in adults, but it is frequently associated with Mycoplasma pneumoniae infection in many cases. This study aimed to investigate the clinical characteristics of pediatric M.
Lanqin Chen, J. Yin, Xiu-yun Liu, Jun Liu, Bao-Ping Xu, Kunling Shen   +5 more
semanticscholar   +1 more source

Identification of Coinfections by Viral and Bacterial Pathogens in COVID-19 Hospitalized Patients in Peru: Molecular Diagnosis and Clinical Characteristics

Antibiotics, 2021
The impact of respiratory coinfections in COVID-19 is still not well understood despite the growing evidence that consider coinfections greater than expected.
Giancarlo Pérez-Lazo, Wilmer Silva-Caso, Juana del Valle-Mendoza, Adriana Morales-Moreno, José Ballena-López, Fernando Soto-Febres, Johanna Martins-Luna, Hugo Carrillo-Ng, Luís J. del Valle, Sungmin Kym, Miguel Angel Aguilar-Luis, Issac Peña-Tuesta, Carmen Tinco-Valdez, Luis Ricardo Illescas   +13 more
doaj   +1 more source

Mycoplasma pneumoniae detections before and during the COVID-19 pandemic: results of a global survey, 2017 to 2021

Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, 2022
Background Mycoplasma pneumoniae respiratory infections are transmitted by aerosol and droplets in close contact. Aim We investigated global M. pneumoniae incidence after implementation of non-pharmaceutical interventions (NPIs) against COVID-19 in March
Patrick M. Meyer Sauteur, M. Beeton, S. Uldum, N. Bossuyt, M. Vermeulen, K. Loens, S. Pereyre, C. Bébéar, D. Keše, J. Day, B. Afshar, V. Chalker, G. Greub, R. Nir-Paz, R. Dumke, Matthias Maiwald   +15 more
semanticscholar   +1 more source

Refractory Mycoplasma pneumoniae Pneumonia in Children: Early Recognition and Management

Journal of Clinical Medicine, 2022
Refractory Mycoplasma pneumoniae pneumonia (RMPP) is a severe state of M. pneumoniae infection that has attracted increasing universal attention in recent years. The pathogenesis of RMPP remains unknown, but the excessive host immune responses as well as
L. Tong, Shumin Huang, Chen Zheng, Yuanyuan Zhang, Zhimin Chen   +4 more
semanticscholar   +1 more source

Insight into the Pathogenic Mechanism of Mycoplasma pneumoniae

Current Microbiology, 2022
Mycoplasma pneumoniae, an obligate parasitic pathogen without cell wall, can cause severe upper and lower respiratory tract symptoms. It is the pathogen of human bronchitis and walking pneumonia, and named community-acquired pneumonia.
Jie Hu, Youyuan Ye, Xinxin Chen, Lu Xiong, Weimin Xie, Peng Liu   +5 more
semanticscholar   +1 more source

A fulminant pneumonia due to Mycoplasma pneumoniae – Case report and literature review

IDCases, 2022
Fulminant pneumonia due to Mycoplasma pneumoniae [MP] is quite rare even though there is a high prevalence of Mycoplasma species infection in the general population.We report a case of an atypical pneumonia with Acute Respiratory Distress Syndrome (ARDS)
Athira Unni, MD, P.K. Hidayathulla, MD, K.P. Kavitha, MD, Mohammed Niyas Paloth, MD, Priyanka Raveendranadhan Nair, MD, Jayesh Kumar P, MD, Chandni Radhakrishnan, MD PhD   +6 more
doaj   +1 more source

Interaction between alveolar macrophages and epithelial cells during Mycoplasma pneumoniae infection

Frontiers in Cellular and Infection Microbiology, 2023
Mycoplasma pneumoniae, as one of the most common pathogens, usually causes upper respiratory tract infections and pneumonia in humans and animals. It accounts for 10% to 40% of community-acquired pneumonia in children. The alveolar epithelial cells (AECs)
Yazhi Xue, Mengyao Wang, Hongbing Han
semanticscholar   +1 more source

Mycoplasma pneumoniae-related extra-pulmonary diseases and antimicrobial therapy

Journal of Microbiology, Immunology and Infection, 2020
The findings by Yang-TI et al. suggested that macrolide-resistance and/or delayed appropriate antimicrobial treatment may contribute to the development of Mycoplasma pneumoniae-related extra-pulmonary diseases in children.
Dimitri Poddighe
doaj   +1 more source